Financial Trading and Investing || Market Efficiency
- 作者Teall, John L.
- 文件大小299.12KB
- 发表时间2013
- DOI10.1016/B978-0-12-391880-2.00011-3
- 页码285-323
Principles of Cancer Biotherapy ||Oldham, Robert K.; Dillman, Robert O. · 2009
Principles of Cancer Biotherapy || ImmunotoxinsOldham, Robert K.; Dillman, Robert O. · 2009
Principles of Cancer Biotherapy || Interferons: therapy for cancerOldham, Robert K.; Dillman, Robert O. · 2009
Letter to the EditorRobert O. Dillman · 2000
Cancer ImmunotherapyDillman, Robert O. · Cancer Biotherapy & Radiopharmaceuticals · 2011
Monoclonal Antibodies as Tumour TherapyDr Robert O. Dillman · BioDrugs · 1994
What to do with IL-2?Dillman, Robert O. · Cancer Biotherapy & Radiopharmaceuticals · 1999
Renal Complications of Infectious DiseasesEknoyan, Garabed; Dillman, Robert O. · Medical Clinics of North America · 1978
<i>Editorial:</i> What Ails Solid Tumor Radioimmunotherapy?Divgi, Chaitanya · Cancer Biotherapy & Radiopharmaceuticals · 2006
Tools for Pretargeted RadioimmunotherapyWu, Anna M. · Cancer Biotherapy & Radiopharmaceuticals · 2001
AmifostineRasey, Janet S. · Cancer Biotherapy & Radiopharmaceuticals · 1999
Cancer ImmunotherapyDillman, Robert O. · Cancer Biotherapy & Radiopharmaceuticals · 2011
Radiobiology of Systemic Radiation TherapyMurray, David; McEwan, Alexander J. · Cancer Biotherapy & Radiopharmaceuticals · 2007
The Immune System and CancerLoose, David; Van de Wiele, Christophe · Cancer Biotherapy & Radiopharmaceuticals · 2009
Fundamentally DifferentOldham, Robert K. · Cancer Biotherapy & Radiopharmaceuticals · 1999
Oral PresentationsCancer Biotherapy & Radiopharmaceuticals · 2004